← Eichor
Study identifier: NCT06726746 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Efficacy of Fractional CO2 Laser Treatment in Post-Menopausal Women With Vaginal Atrophy

Condition: Post Menopausal Vaginal Atrophy  ·  Sponsor: Cairo University

PhaseNA
Planned participants20
Who can joinFemale, 45 Years to 65 Years
Healthy volunteersNo

About this study

Vaginal dryness, itching, burning, irritability, secretion, and various urinary problems are the symptoms of vulvovaginal atrophy. Therefore, more attention must be paid to relieve these symptoms in order to provide better sexual health for postmenopausal women. At present, an accumulating body of evidence suggests safety and efficacy of laser and energy-based devices for the treatment of women's genitourinary conditions. More clinical studies are needed to assess the safety profile and clinical outcomes of the lasers and energy-based devices to treat the symptoms associated with vulvovaginal atrophy (VVA)

This description comes directly from the study's public registry record.

Talk to the study team

Daniel Onsi  ·  +201272755335  ·  daniel.onsi@ngu.edu.eg

Mohammed El-Noury  ·  +201222146848  ·  Amr_elnoury@yahoo.com

Always discuss trial participation with your own doctor first.

Locations (1)

Cairo UniversityCairo, EgyptRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT06726746